nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—nerve—multiple sclerosis	0.0206	0.0637	CbGeAlD
Acamprosate—GRIN2B—nerve—multiple sclerosis	0.0163	0.0503	CbGeAlD
Acamprosate—GRIN2A—nerve—multiple sclerosis	0.0142	0.044	CbGeAlD
Acamprosate—GRM5—brainstem—multiple sclerosis	0.0116	0.0359	CbGeAlD
Acamprosate—GRIN2C—brainstem—multiple sclerosis	0.00883	0.0273	CbGeAlD
Acamprosate—GRIN2D—brainstem—multiple sclerosis	0.00821	0.0254	CbGeAlD
Acamprosate—GRM5—midbrain—multiple sclerosis	0.00739	0.0229	CbGeAlD
Acamprosate—GRIN1—brainstem—multiple sclerosis	0.00732	0.0227	CbGeAlD
Acamprosate—GRM5—spinal cord—multiple sclerosis	0.00721	0.0223	CbGeAlD
Acamprosate—GRIN2B—brainstem—multiple sclerosis	0.00698	0.0216	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—multiple sclerosis	0.00616	0.0191	CbGeAlD
Acamprosate—GRIN2A—brainstem—multiple sclerosis	0.0061	0.0189	CbGeAlD
Acamprosate—GRM5—nervous system—multiple sclerosis	0.00607	0.0188	CbGeAlD
Acamprosate—SLC36A1—brainstem—multiple sclerosis	0.00607	0.0188	CbGeAlD
Acamprosate—GRM5—central nervous system—multiple sclerosis	0.00585	0.0181	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—multiple sclerosis	0.00573	0.0177	CbGeAlD
Acamprosate—GRM5—cerebellum—multiple sclerosis	0.00572	0.0177	CbGeAlD
Acamprosate—GRIN2D—spinal cord—multiple sclerosis	0.00511	0.0158	CbGeAlD
Acamprosate—GRIN1—midbrain—multiple sclerosis	0.00467	0.0144	CbGeAlD
Acamprosate—GRM5—brain—multiple sclerosis	0.00464	0.0144	CbGeAlD
Acamprosate—GRIN2C—nervous system—multiple sclerosis	0.00463	0.0143	CbGeAlD
Acamprosate—GRIN1—spinal cord—multiple sclerosis	0.00455	0.0141	CbGeAlD
Acamprosate—GRIN2C—central nervous system—multiple sclerosis	0.00446	0.0138	CbGeAlD
Acamprosate—GRIN2C—cerebellum—multiple sclerosis	0.00436	0.0135	CbGeAlD
Acamprosate—GRIN2B—spinal cord—multiple sclerosis	0.00434	0.0134	CbGeAlD
Acamprosate—GRIN2D—nervous system—multiple sclerosis	0.0043	0.0133	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—multiple sclerosis	0.00426	0.0132	CbGeAlD
Acamprosate—GRIN2D—central nervous system—multiple sclerosis	0.00414	0.0128	CbGeAlD
Acamprosate—GRIN2D—cerebellum—multiple sclerosis	0.00405	0.0125	CbGeAlD
Acamprosate—GRIN3A—nervous system—multiple sclerosis	0.00405	0.0125	CbGeAlD
Acamprosate—GRIN3A—central nervous system—multiple sclerosis	0.00389	0.0121	CbGeAlD
Acamprosate—GRIN2A—midbrain—multiple sclerosis	0.00389	0.012	CbGeAlD
Acamprosate—GRIN1—nervous system—multiple sclerosis	0.00384	0.0119	CbGeAlD
Acamprosate—GRIN2A—spinal cord—multiple sclerosis	0.0038	0.0117	CbGeAlD
Acamprosate—GRIN1—central nervous system—multiple sclerosis	0.00369	0.0114	CbGeAlD
Acamprosate—GRIN2B—nervous system—multiple sclerosis	0.00366	0.0113	CbGeAlD
Acamprosate—GRIN1—cerebellum—multiple sclerosis	0.00361	0.0112	CbGeAlD
Acamprosate—GRIN2C—brain—multiple sclerosis	0.00354	0.0109	CbGeAlD
Acamprosate—GRIN2B—central nervous system—multiple sclerosis	0.00352	0.0109	CbGeAlD
Acamprosate—GRIN2B—cerebellum—multiple sclerosis	0.00344	0.0107	CbGeAlD
Acamprosate—GABRA1—brainstem—multiple sclerosis	0.0034	0.0105	CbGeAlD
Acamprosate—GRIN2D—brain—multiple sclerosis	0.00329	0.0102	CbGeAlD
Acamprosate—GRIN2A—nervous system—multiple sclerosis	0.0032	0.0099	CbGeAlD
Acamprosate—SLC36A1—nervous system—multiple sclerosis	0.00318	0.00983	CbGeAlD
Acamprosate—GRIN3A—brain—multiple sclerosis	0.00309	0.00957	CbGeAlD
Acamprosate—GRIN2A—central nervous system—multiple sclerosis	0.00308	0.00953	CbGeAlD
Acamprosate—SLC36A1—central nervous system—multiple sclerosis	0.00306	0.00947	CbGeAlD
Acamprosate—GRIN2A—cerebellum—multiple sclerosis	0.00301	0.00931	CbGeAlD
Acamprosate—SLC36A1—cerebellum—multiple sclerosis	0.00299	0.00925	CbGeAlD
Acamprosate—GRIN1—brain—multiple sclerosis	0.00293	0.00907	CbGeAlD
Acamprosate—GRIN2B—brain—multiple sclerosis	0.0028	0.00865	CbGeAlD
Acamprosate—GABRG2—medulla oblongata—multiple sclerosis	0.00268	0.0083	CbGeAlD
Acamprosate—GABRG2—midbrain—multiple sclerosis	0.00245	0.00758	CbGeAlD
Acamprosate—GRIN2A—brain—multiple sclerosis	0.00244	0.00756	CbGeAlD
Acamprosate—SLC36A1—brain—multiple sclerosis	0.00243	0.00752	CbGeAlD
Acamprosate—GABRG2—spinal cord—multiple sclerosis	0.00239	0.0074	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—multiple sclerosis	0.00237	0.00733	CbGeAlD
Acamprosate—GABRA1—midbrain—multiple sclerosis	0.00216	0.0067	CbGeAlD
Acamprosate—GABRA1—spinal cord—multiple sclerosis	0.00211	0.00653	CbGeAlD
Acamprosate—GABRB3—medulla oblongata—multiple sclerosis	0.00206	0.00637	CbGeAlD
Acamprosate—GABRG2—nervous system—multiple sclerosis	0.00201	0.00623	CbGeAlD
Acamprosate—GABRG2—central nervous system—multiple sclerosis	0.00194	0.006	CbGeAlD
Acamprosate—GABRG2—cerebellum—multiple sclerosis	0.0019	0.00587	CbGeAlD
Acamprosate—GABRB3—midbrain—multiple sclerosis	0.00188	0.00582	CbGeAlD
Acamprosate—GABRB3—spinal cord—multiple sclerosis	0.00184	0.00568	CbGeAlD
Acamprosate—GABRA1—nervous system—multiple sclerosis	0.00178	0.0055	CbGeAlD
Acamprosate—GABRA1—central nervous system—multiple sclerosis	0.00171	0.0053	CbGeAlD
Acamprosate—GABRA1—cerebellum—multiple sclerosis	0.00167	0.00518	CbGeAlD
Acamprosate—GABRB3—nervous system—multiple sclerosis	0.00155	0.00479	CbGeAlD
Acamprosate—GABRG2—brain—multiple sclerosis	0.00154	0.00477	CbGeAlD
Acamprosate—GABRB3—central nervous system—multiple sclerosis	0.00149	0.00461	CbGeAlD
Acamprosate—GABRB3—cerebellum—multiple sclerosis	0.00146	0.00451	CbGeAlD
Acamprosate—GABRA1—brain—multiple sclerosis	0.00136	0.00421	CbGeAlD
Acamprosate—GABRB3—brain—multiple sclerosis	0.00118	0.00366	CbGeAlD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000841	0.00484	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—KCNA3—multiple sclerosis	0.000834	0.0048	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000822	0.00473	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00081	0.00466	CbGpPWpGaD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000783	0.0045	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—APOE—multiple sclerosis	0.000782	0.0045	CbGpPWpGaD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000782	0.0045	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL3—multiple sclerosis	0.000764	0.0044	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000753	0.00433	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—S1PR1—multiple sclerosis	0.000747	0.0043	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—FAS—multiple sclerosis	0.000743	0.00428	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00074	0.00426	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—MAPK1—multiple sclerosis	0.000739	0.00425	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—PTGER4—multiple sclerosis	0.000736	0.00423	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000727	0.00419	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—FAS—multiple sclerosis	0.000724	0.00417	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—MAPK1—multiple sclerosis	0.00072	0.00414	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCR3—multiple sclerosis	0.000711	0.00409	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000701	0.00404	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—RGS1—multiple sclerosis	0.000699	0.00402	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—MAPK1—multiple sclerosis	0.000697	0.00401	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR2—multiple sclerosis	0.000691	0.00398	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000683	0.00393	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—APOE—multiple sclerosis	0.000682	0.00392	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000665	0.00383	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—APOE—multiple sclerosis	0.000665	0.00383	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CNR1—multiple sclerosis	0.000664	0.00382	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GPR65—multiple sclerosis	0.000663	0.00381	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—multiple sclerosis	0.000653	0.00376	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CNR1—multiple sclerosis	0.000647	0.00373	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000642	0.00369	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CNR1—multiple sclerosis	0.000638	0.00367	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RGS1—multiple sclerosis	0.000635	0.00365	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—BDNF—multiple sclerosis	0.00063	0.00362	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—BCHE—multiple sclerosis	0.00062	0.00357	CbGpPWpGaD
Acamprosate—GRIN2B—ErbB4 signaling events—MAPK1—multiple sclerosis	0.000619	0.00356	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000618	0.00356	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—MAPK1—multiple sclerosis	0.000608	0.0035	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—multiple sclerosis	0.000607	0.00349	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR1—multiple sclerosis	0.000606	0.00349	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000606	0.00349	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GPR65—multiple sclerosis	0.000602	0.00346	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—MAPK1—multiple sclerosis	0.000592	0.00341	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000585	0.00337	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL4—multiple sclerosis	0.000585	0.00337	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LINGO1—multiple sclerosis	0.000582	0.00335	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—BCHE—multiple sclerosis	0.000577	0.00332	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL10—multiple sclerosis	0.000574	0.00331	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.00056	0.00322	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000551	0.00317	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR1—multiple sclerosis	0.00055	0.00317	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL13—multiple sclerosis	0.00055	0.00317	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000548	0.00316	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000546	0.00314	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000539	0.0031	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BDNF—multiple sclerosis	0.000537	0.00309	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000526	0.00302	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BDNF—multiple sclerosis	0.000524	0.00301	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000517	0.00298	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TAGAP—multiple sclerosis	0.000505	0.0029	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000504	0.0029	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—multiple sclerosis	0.000498	0.00287	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000497	0.00286	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL5—multiple sclerosis	0.000494	0.00285	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TLR4—multiple sclerosis	0.000485	0.00279	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PRNP—multiple sclerosis	0.000484	0.00278	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000481	0.00277	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—SPP1—multiple sclerosis	0.000477	0.00274	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—multiple sclerosis	0.000474	0.00273	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—BCHE—multiple sclerosis	0.000474	0.00273	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PRNP—multiple sclerosis	0.000471	0.00271	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—SPP1—multiple sclerosis	0.000465	0.00267	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—ICAM1—multiple sclerosis	0.000465	0.00267	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—MAPK1—multiple sclerosis	0.000462	0.00266	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR5—multiple sclerosis	0.000445	0.00256	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—S1PR1—multiple sclerosis	0.000441	0.00254	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—multiple sclerosis	0.00044	0.00253	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	0.000438	0.00252	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—multiple sclerosis	0.000435	0.0025	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GPC5—multiple sclerosis	0.000429	0.00247	CbGpPWpGaD
Acamprosate—Malaise—Dexamethasone—multiple sclerosis	0.000425	0.000844	CcSEcCtD
Acamprosate—Malaise—Betamethasone—multiple sclerosis	0.000425	0.000844	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—multiple sclerosis	0.000424	0.00244	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000424	0.000842	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—multiple sclerosis	0.000423	0.000841	CcSEcCtD
Acamprosate—Vertigo—Dexamethasone—multiple sclerosis	0.000423	0.000841	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000423	0.00084	CcSEcCtD
Acamprosate—Syncope—Betamethasone—multiple sclerosis	0.000422	0.00084	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—multiple sclerosis	0.000422	0.00084	CcSEcCtD
Acamprosate—Infection—Triamcinolone—multiple sclerosis	0.000421	0.000837	CcSEcCtD
Acamprosate—Sweating—Methotrexate—multiple sclerosis	0.000421	0.000836	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—multiple sclerosis	0.00042	0.000835	CcSEcCtD
Acamprosate—Haematuria—Methotrexate—multiple sclerosis	0.000418	0.000831	CcSEcCtD
Acamprosate—Shock—Triamcinolone—multiple sclerosis	0.000417	0.000829	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—multiple sclerosis	0.000417	0.000828	CcSEcCtD
Acamprosate—Alopecia—Prednisone—multiple sclerosis	0.000416	0.000828	CcSEcCtD
Acamprosate—Shock—Methylprednisolone—multiple sclerosis	0.000416	0.000827	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CCL2—multiple sclerosis	0.000416	0.00239	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000416	0.00239	CbGpPWpGaD
Acamprosate—Loss of consciousness—Betamethasone—multiple sclerosis	0.000414	0.000823	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000414	0.000823	CcSEcCtD
Acamprosate—Epistaxis—Methotrexate—multiple sclerosis	0.000414	0.000823	CcSEcCtD
Acamprosate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000414	0.000822	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—multiple sclerosis	0.000414	0.000822	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—multiple sclerosis	0.000414	0.000822	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—BCHE—multiple sclerosis	0.000413	0.00238	CbGpPWpGaD
Acamprosate—Mental disorder—Prednisone—multiple sclerosis	0.000413	0.000821	CcSEcCtD
Acamprosate—Nausea—Azathioprine—multiple sclerosis	0.000413	0.00082	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000413	0.00082	CcSEcCtD
Acamprosate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000411	0.000816	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—multiple sclerosis	0.00041	0.000815	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00041	0.000814	CcSEcCtD
Acamprosate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000409	0.000812	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—multiple sclerosis	0.000408	0.000811	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—multiple sclerosis	0.000408	0.000811	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—multiple sclerosis	0.000407	0.000808	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—multiple sclerosis	0.000407	0.000808	CcSEcCtD
Acamprosate—Asthenia—Mitoxantrone—multiple sclerosis	0.000403	0.000801	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—BCHE—multiple sclerosis	0.000403	0.00232	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000402	0.00231	CbGpPWpGaD
Acamprosate—Myalgia—Betamethasone—multiple sclerosis	0.000401	0.000797	CcSEcCtD
Acamprosate—Myalgia—Dexamethasone—multiple sclerosis	0.000401	0.000797	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—multiple sclerosis	0.0004	0.000794	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—multiple sclerosis	0.0004	0.000794	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—multiple sclerosis	0.000396	0.000788	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—multiple sclerosis	0.000396	0.000788	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—multiple sclerosis	0.000396	0.000787	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—multiple sclerosis	0.000395	0.000785	CcSEcCtD
Acamprosate—Pain—Prednisolone—multiple sclerosis	0.000394	0.000783	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—multiple sclerosis	0.000394	0.000783	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—multiple sclerosis	0.000394	0.000783	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL3—multiple sclerosis	0.000392	0.00226	CbGpPWpGaD
Acamprosate—Pharyngitis—Methotrexate—multiple sclerosis	0.000391	0.000777	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CCR2—multiple sclerosis	0.000391	0.00225	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000386	0.000767	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000385	0.000766	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000384	0.000764	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000384	0.000764	CcSEcCtD
Acamprosate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000384	0.000764	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—multiple sclerosis	0.000383	0.000762	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—multiple sclerosis	0.000382	0.00076	CcSEcCtD
Acamprosate—Infection—Dexamethasone—multiple sclerosis	0.000382	0.000759	CcSEcCtD
Acamprosate—Infection—Betamethasone—multiple sclerosis	0.000382	0.000759	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000381	0.000757	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—multiple sclerosis	0.00038	0.000756	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—MAPK1—multiple sclerosis	0.00038	0.00219	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisolone—multiple sclerosis	0.00038	0.000755	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00038	0.000755	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—multiple sclerosis	0.00038	0.000754	CcSEcCtD
Acamprosate—Anaemia—Prednisone—multiple sclerosis	0.000379	0.000754	CcSEcCtD
Acamprosate—Shock—Dexamethasone—multiple sclerosis	0.000378	0.000752	CcSEcCtD
Acamprosate—Shock—Betamethasone—multiple sclerosis	0.000378	0.000752	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000378	0.000751	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PTGER4—multiple sclerosis	0.000378	0.00217	CbGpPWpGaD
Acamprosate—Agitation—Prednisone—multiple sclerosis	0.000377	0.000749	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000376	0.000748	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000376	0.000748	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PTPRC—multiple sclerosis	0.000376	0.00216	CbGpPWpGaD
Acamprosate—Tachycardia—Dexamethasone—multiple sclerosis	0.000375	0.000746	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—multiple sclerosis	0.000375	0.000746	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—RGS1—multiple sclerosis	0.000375	0.00216	CbGpPWpGaD
Acamprosate—Angioedema—Prednisone—multiple sclerosis	0.000375	0.000745	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000373	0.000741	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000372	0.00074	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000372	0.000739	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000372	0.000739	CcSEcCtD
Acamprosate—Malaise—Prednisone—multiple sclerosis	0.00037	0.000735	CcSEcCtD
Acamprosate—Vertigo—Prednisone—multiple sclerosis	0.000369	0.000733	CcSEcCtD
Acamprosate—Syncope—Prednisone—multiple sclerosis	0.000368	0.000731	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—multiple sclerosis	0.000367	0.00073	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—PTPRC—multiple sclerosis	0.000367	0.00211	CbGpPWpGaD
Acamprosate—Anorexia—Dexamethasone—multiple sclerosis	0.000366	0.000728	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—multiple sclerosis	0.000366	0.000728	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000366	0.00211	CbGpPWpGaD
Acamprosate—Urticaria—Prednisolone—multiple sclerosis	0.000366	0.000728	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCR3—multiple sclerosis	0.000365	0.0021	CbGpPWpGaD
Acamprosate—Pain—Triamcinolone—multiple sclerosis	0.000362	0.00072	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000362	0.00208	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—multiple sclerosis	0.000362	0.00208	CbGpPWpGaD
Acamprosate—Loss of consciousness—Prednisone—multiple sclerosis	0.000361	0.000717	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CNR1—multiple sclerosis	0.00036	0.00207	CbGpPWpGaD
Acamprosate—Hypotension—Dexamethasone—multiple sclerosis	0.000359	0.000714	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—multiple sclerosis	0.000359	0.000714	CcSEcCtD
Acamprosate—Vomiting—Mitoxantrone—multiple sclerosis	0.000357	0.00071	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—multiple sclerosis	0.000357	0.00205	CbGpPWpGaD
Acamprosate—Immune system disorder—Methotrexate—multiple sclerosis	0.000356	0.000707	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000356	0.00205	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000356	0.00205	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GPR65—multiple sclerosis	0.000356	0.00205	CbGpPWpGaD
Acamprosate—Convulsion—Prednisone—multiple sclerosis	0.000355	0.000706	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCR2—multiple sclerosis	0.000355	0.00204	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	0.000354	0.00204	CbGpPWpGaD
Acamprosate—Hypertension—Prednisone—multiple sclerosis	0.000354	0.000704	CcSEcCtD
Acamprosate—Rash—Mitoxantrone—multiple sclerosis	0.000354	0.000704	CcSEcCtD
Acamprosate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000354	0.000703	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—multiple sclerosis	0.000354	0.00203	CbGpPWpGaD
Acamprosate—Chills—Methotrexate—multiple sclerosis	0.000353	0.000702	CcSEcCtD
Acamprosate—Headache—Mitoxantrone—multiple sclerosis	0.000352	0.000699	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00035	0.000696	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00035	0.000696	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000349	0.00201	CbGpPWpGaD
Acamprosate—Myalgia—Prednisone—multiple sclerosis	0.000349	0.000694	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—multiple sclerosis	0.000349	0.000694	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000349	0.000694	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000349	0.00201	CbGpPWpGaD
Acamprosate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000348	0.000692	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—POMC—multiple sclerosis	0.000348	0.002	CbGpPWpGaD
Acamprosate—Anxiety—Prednisone—multiple sclerosis	0.000348	0.000692	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—multiple sclerosis	0.000348	0.000692	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—multiple sclerosis	0.000348	0.000691	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—multiple sclerosis	0.000348	0.000691	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—multiple sclerosis	0.000348	0.002	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000347	0.000689	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000346	0.000687	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—multiple sclerosis	0.000345	0.000686	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000345	0.000686	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PRNP—multiple sclerosis	0.000345	0.00199	CbGpPWpGaD
Acamprosate—Discomfort—Prednisone—multiple sclerosis	0.000345	0.000686	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—multiple sclerosis	0.000345	0.000686	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—multiple sclerosis	0.000343	0.000681	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL2—multiple sclerosis	0.000341	0.00196	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000339	0.000675	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000338	0.000673	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—multiple sclerosis	0.000338	0.000673	CcSEcCtD
Acamprosate—Urticaria—Triamcinolone—multiple sclerosis	0.000337	0.000669	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PRNP—multiple sclerosis	0.000336	0.00194	CbGpPWpGaD
Acamprosate—Urticaria—Methylprednisolone—multiple sclerosis	0.000336	0.000668	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—multiple sclerosis	0.000336	0.000667	CcSEcCtD
Acamprosate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000335	0.000666	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000335	0.000665	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000334	0.000664	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—multiple sclerosis	0.000334	0.000664	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000334	0.000664	CcSEcCtD
Acamprosate—Nausea—Mitoxantrone—multiple sclerosis	0.000334	0.000663	CcSEcCtD
Acamprosate—Infection—Prednisone—multiple sclerosis	0.000333	0.000661	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000332	0.00066	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000332	0.00066	CcSEcCtD
Acamprosate—Back pain—Methotrexate—multiple sclerosis	0.000332	0.000659	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—MAPK1—multiple sclerosis	0.000331	0.00191	CbGpPWpGaD
Acamprosate—Shock—Prednisone—multiple sclerosis	0.000329	0.000655	CcSEcCtD
Acamprosate—Pain—Betamethasone—multiple sclerosis	0.000329	0.000653	CcSEcCtD
Acamprosate—Pain—Dexamethasone—multiple sclerosis	0.000329	0.000653	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CNR1—multiple sclerosis	0.000327	0.00188	CbGpPWpGaD
Acamprosate—Tachycardia—Prednisone—multiple sclerosis	0.000327	0.000649	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—multiple sclerosis	0.000325	0.000646	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CXCL13—multiple sclerosis	0.000325	0.00187	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR1—multiple sclerosis	0.000325	0.00187	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000325	0.00187	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000324	0.000643	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK1—multiple sclerosis	0.000323	0.00186	CbGpPWpGaD
Acamprosate—Anorexia—Prednisone—multiple sclerosis	0.000319	0.000634	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000318	0.000632	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—multiple sclerosis	0.000317	0.00063	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000317	0.00063	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000317	0.00063	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TNF—multiple sclerosis	0.000315	0.00182	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—multiple sclerosis	0.000315	0.00181	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000315	0.00181	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	0.000314	0.00181	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000314	0.000625	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000314	0.000625	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—multiple sclerosis	0.000314	0.00181	CbGpPWpGaD
Acamprosate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000312	0.00062	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000311	0.000619	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000311	0.00179	CbGpPWpGaD
Acamprosate—Malaise—Methotrexate—multiple sclerosis	0.000309	0.000615	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—multiple sclerosis	0.000308	0.000612	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—multiple sclerosis	0.000307	0.00177	CbGpPWpGaD
Acamprosate—Leukopenia—Methotrexate—multiple sclerosis	0.000307	0.00061	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—multiple sclerosis	0.000305	0.000607	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—multiple sclerosis	0.000305	0.000607	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000305	0.00176	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000305	0.000606	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—multiple sclerosis	0.000305	0.000606	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—multiple sclerosis	0.000304	0.000604	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—multiple sclerosis	0.000304	0.000604	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—multiple sclerosis	0.000304	0.000604	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000304	0.000604	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000304	0.000604	CcSEcCtD
Acamprosate—Asthenia—Methylprednisolone—multiple sclerosis	0.000303	0.000603	CcSEcCtD
Acamprosate—Insomnia—Prednisone—multiple sclerosis	0.000303	0.000602	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—multiple sclerosis	0.000301	0.000598	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—multiple sclerosis	0.0003	0.000596	CcSEcCtD
Acamprosate—Cough—Methotrexate—multiple sclerosis	0.000299	0.000595	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—multiple sclerosis	0.000299	0.000595	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—multiple sclerosis	0.000297	0.00171	CbGpPWpGaD
Acamprosate—Convulsion—Methotrexate—multiple sclerosis	0.000297	0.00059	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCL10—multiple sclerosis	0.000295	0.0017	CbGpPWpGaD
Acamprosate—Dyspepsia—Prednisone—multiple sclerosis	0.000295	0.000586	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000293	0.00168	CbGpPWpGaD
Acamprosate—Myalgia—Methotrexate—multiple sclerosis	0.000292	0.00058	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—multiple sclerosis	0.000292	0.00058	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—multiple sclerosis	0.000292	0.00058	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—multiple sclerosis	0.000291	0.000578	CcSEcCtD
Acamprosate—Rash—Prednisolone—multiple sclerosis	0.00029	0.000577	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—multiple sclerosis	0.00029	0.000577	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00029	0.000576	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000289	0.000575	CcSEcCtD
Acamprosate—Headache—Prednisolone—multiple sclerosis	0.000289	0.000574	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—multiple sclerosis	0.000288	0.000573	CcSEcCtD
Acamprosate—Constipation—Prednisone—multiple sclerosis	0.000286	0.000569	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000285	0.00164	CbGpPWpGaD
Acamprosate—Confusional state—Methotrexate—multiple sclerosis	0.000282	0.000561	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—multiple sclerosis	0.00028	0.000557	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00028	0.000556	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—multiple sclerosis	0.00028	0.000556	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000279	0.00161	CbGpPWpGaD
Acamprosate—Infection—Methotrexate—multiple sclerosis	0.000278	0.000553	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—multiple sclerosis	0.000276	0.000548	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—multiple sclerosis	0.000276	0.000548	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—multiple sclerosis	0.000276	0.000548	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000274	0.00158	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000274	0.000545	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000274	0.000544	CcSEcCtD
Acamprosate—Nausea—Prednisolone—multiple sclerosis	0.000274	0.000544	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—BCHE—multiple sclerosis	0.000273	0.00157	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000272	0.00157	CbGpPWpGaD
Acamprosate—Pruritus—Betamethasone—multiple sclerosis	0.000272	0.000541	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—multiple sclerosis	0.000272	0.000541	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—multiple sclerosis	0.000272	0.00054	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00027	0.000538	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000269	0.00155	CbGpPWpGaD
Acamprosate—Vomiting—Triamcinolone—multiple sclerosis	0.000269	0.000535	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—multiple sclerosis	0.000269	0.000534	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PTPRC—multiple sclerosis	0.000268	0.00154	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000268	0.00154	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000268	0.00154	CbGpPWpGaD
Acamprosate—Rash—Triamcinolone—multiple sclerosis	0.000267	0.000531	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—multiple sclerosis	0.000267	0.000531	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—multiple sclerosis	0.000267	0.00053	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—multiple sclerosis	0.000267	0.00053	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000266	0.000529	CcSEcCtD
Acamprosate—Urticaria—Prednisone—multiple sclerosis	0.000266	0.000529	CcSEcCtD
Acamprosate—Headache—Triamcinolone—multiple sclerosis	0.000265	0.000528	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—multiple sclerosis	0.000265	0.000526	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—multiple sclerosis	0.000265	0.000526	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—multiple sclerosis	0.000265	0.000526	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000263	0.000523	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—multiple sclerosis	0.000263	0.000523	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PTPRC—multiple sclerosis	0.000262	0.00151	CbGpPWpGaD
Acamprosate—Hypotension—Methotrexate—multiple sclerosis	0.000261	0.00052	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000255	0.000507	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—multiple sclerosis	0.000254	0.000505	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—multiple sclerosis	0.000254	0.000505	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL5—multiple sclerosis	0.000254	0.00146	CbGpPWpGaD
Acamprosate—Insomnia—Methotrexate—multiple sclerosis	0.000253	0.000503	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000252	0.00145	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—multiple sclerosis	0.000252	0.00145	CbGpPWpGaD
Acamprosate—Nausea—Triamcinolone—multiple sclerosis	0.000252	0.0005	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—multiple sclerosis	0.000251	0.000499	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—multiple sclerosis	0.000251	0.000499	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—multiple sclerosis	0.000249	0.000496	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—multiple sclerosis	0.000249	0.000494	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000248	0.00143	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisone—multiple sclerosis	0.000247	0.00049	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—multiple sclerosis	0.000246	0.00049	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—multiple sclerosis	0.000246	0.00141	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000245	0.00141	CbGpPWpGaD
Acamprosate—Vomiting—Betamethasone—multiple sclerosis	0.000244	0.000486	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—multiple sclerosis	0.000244	0.000486	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—multiple sclerosis	0.000243	0.000483	CcSEcCtD
Acamprosate—Rash—Betamethasone—multiple sclerosis	0.000242	0.000482	CcSEcCtD
Acamprosate—Rash—Dexamethasone—multiple sclerosis	0.000242	0.000482	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—multiple sclerosis	0.000242	0.000481	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—multiple sclerosis	0.000242	0.000481	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000242	0.00048	CcSEcCtD
Acamprosate—Headache—Dexamethasone—multiple sclerosis	0.000241	0.000479	CcSEcCtD
Acamprosate—Headache—Betamethasone—multiple sclerosis	0.000241	0.000479	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK1—multiple sclerosis	0.00024	0.00138	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.00024	0.00138	CbGpPWpGaD
Acamprosate—Asthenia—Prednisone—multiple sclerosis	0.00024	0.000477	CcSEcCtD
Acamprosate—Pain—Methotrexate—multiple sclerosis	0.000239	0.000476	CcSEcCtD
Acamprosate—Pruritus—Prednisone—multiple sclerosis	0.000237	0.000471	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000237	0.00136	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000236	0.00136	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000234	0.00135	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL3—multiple sclerosis	0.000232	0.00133	CbGpPWpGaD
Acamprosate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000231	0.000458	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—multiple sclerosis	0.000229	0.000455	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—multiple sclerosis	0.000229	0.00132	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000229	0.000455	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCR5—multiple sclerosis	0.000229	0.00132	CbGpPWpGaD
Acamprosate—Nausea—Betamethasone—multiple sclerosis	0.000228	0.000454	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—multiple sclerosis	0.000228	0.000454	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—multiple sclerosis	0.000225	0.0013	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2RA—multiple sclerosis	0.000225	0.0013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTGER4—multiple sclerosis	0.000223	0.00128	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—multiple sclerosis	0.000222	0.000442	CcSEcCtD
Acamprosate—Dizziness—Prednisone—multiple sclerosis	0.000221	0.00044	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—multiple sclerosis	0.000221	0.00044	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—multiple sclerosis	0.000221	0.00044	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00022	0.00127	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—multiple sclerosis	0.00022	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PGR—multiple sclerosis	0.00022	0.00126	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000217	0.00125	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR3—multiple sclerosis	0.000215	0.00124	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD28—multiple sclerosis	0.000213	0.00123	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000213	0.00123	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—multiple sclerosis	0.000213	0.000423	CcSEcCtD
Acamprosate—Rash—Prednisone—multiple sclerosis	0.000211	0.00042	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—multiple sclerosis	0.000211	0.000419	CcSEcCtD
Acamprosate—Headache—Prednisone—multiple sclerosis	0.00021	0.000417	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.00021	0.00121	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR2—multiple sclerosis	0.00021	0.00121	CbGpPWpGaD
Acamprosate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000206	0.00041	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000205	0.00118	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000204	0.00118	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—multiple sclerosis	0.000201	0.000399	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK1—multiple sclerosis	0.0002	0.00115	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—multiple sclerosis	0.000199	0.000395	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—multiple sclerosis	0.000198	0.000393	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—POMC—multiple sclerosis	0.000197	0.00113	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CNR1—multiple sclerosis	0.000193	0.00111	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000192	0.0011	CbGpPWpGaD
Acamprosate—Diarrhoea—Methotrexate—multiple sclerosis	0.000191	0.000381	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000188	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000186	0.00107	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000186	0.00107	CbGpPWpGaD
Acamprosate—Dizziness—Methotrexate—multiple sclerosis	0.000185	0.000368	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—multiple sclerosis	0.000185	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000183	0.00105	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAPK1—multiple sclerosis	0.000181	0.00104	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000181	0.00104	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—multiple sclerosis	0.000179	0.00103	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—multiple sclerosis	0.000178	0.000354	CcSEcCtD
Acamprosate—Rash—Methotrexate—multiple sclerosis	0.000176	0.000351	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—multiple sclerosis	0.000176	0.00035	CcSEcCtD
Acamprosate—Headache—Methotrexate—multiple sclerosis	0.000175	0.000348	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL2—multiple sclerosis	0.000175	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—multiple sclerosis	0.000174	0.001	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAPK1—multiple sclerosis	0.000169	0.00097	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—TYK2—multiple sclerosis	0.000168	0.000969	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—multiple sclerosis	0.000166	0.00033	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000165	0.000947	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—TYK2—multiple sclerosis	0.000164	0.000944	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TYK2—multiple sclerosis	0.000159	0.000913	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000158	0.000907	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000154	0.000884	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD86—multiple sclerosis	0.000152	0.000876	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—multiple sclerosis	0.00015	0.000863	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	0.000149	0.000856	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000148	0.00085	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—multiple sclerosis	0.000145	0.000837	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000143	0.000822	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—multiple sclerosis	0.000139	0.000799	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—multiple sclerosis	0.000138	0.000797	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000138	0.000796	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000136	0.000781	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000135	0.000778	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—multiple sclerosis	0.000135	0.000777	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RA—multiple sclerosis	0.000133	0.000766	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—multiple sclerosis	0.000133	0.000763	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—multiple sclerosis	0.000132	0.00076	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—multiple sclerosis	0.000129	0.000744	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—multiple sclerosis	0.000123	0.000707	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—multiple sclerosis	0.000121	0.000695	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TYK2—multiple sclerosis	0.00012	0.000691	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000119	0.000683	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAPK1—multiple sclerosis	0.000118	0.000677	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TYK2—multiple sclerosis	0.000117	0.000674	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—multiple sclerosis	0.000111	0.000639	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—multiple sclerosis	0.000107	0.000616	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—multiple sclerosis	0.000106	0.000607	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—multiple sclerosis	0.000104	0.000601	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000104	0.000598	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000104	0.000596	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—multiple sclerosis	0.000103	0.000594	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000102	0.000587	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—multiple sclerosis	0.000101	0.000581	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—multiple sclerosis	9.46e-05	0.000544	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TYK2—multiple sclerosis	9.38e-05	0.00054	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—multiple sclerosis	9.22e-05	0.000531	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.92e-05	0.000513	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—multiple sclerosis	8.41e-05	0.000484	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.36e-05	0.000481	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—multiple sclerosis	8.23e-05	0.000474	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—multiple sclerosis	8.2e-05	0.000472	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—multiple sclerosis	8.02e-05	0.000462	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—multiple sclerosis	7.96e-05	0.000458	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—multiple sclerosis	7.82e-05	0.00045	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—multiple sclerosis	7.8e-05	0.000449	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—multiple sclerosis	7.79e-05	0.000449	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—multiple sclerosis	7.76e-05	0.000447	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—multiple sclerosis	7.64e-05	0.00044	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—multiple sclerosis	7.6e-05	0.000437	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—multiple sclerosis	7.45e-05	0.000429	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—multiple sclerosis	7.38e-05	0.000425	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—multiple sclerosis	7.28e-05	0.000419	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—multiple sclerosis	7.09e-05	0.000408	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.9e-05	0.000397	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—multiple sclerosis	6.84e-05	0.000393	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.78e-05	0.00039	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—multiple sclerosis	6.56e-05	0.000378	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—multiple sclerosis	6.1e-05	0.000351	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—multiple sclerosis	6.09e-05	0.00035	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.97e-05	0.000343	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.93e-05	0.000341	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—multiple sclerosis	5.87e-05	0.000338	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—multiple sclerosis	5.73e-05	0.00033	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—multiple sclerosis	4.59e-05	0.000264	CbGpPWpGaD
